News About: Pharm. Industry
GSK, Daewoong to face class action suit
GlaxoSmithKline (GSK) will face a possible class action suit by a group of patients and consumers saying GSK colluded with Dong-A Pharm to hinder the generic sale of its anti-emetic Zofran for the past 12 years.
Th...
Competition stiff for OTC drugs
Multinational pharmaceutical companies are stepping up their marketing in domestic over-the-counter (OTC) drug market, which is forecast to become more competitive than ever this year, according to industry sources.
...
Shinpoong inks new biopharmaceutical tie-up
Shinpoong Pharm said Tuesday signed a term sheet agreement with France-based LFB S.A. to set up a biopharmaceutical joint venture by March.
In its regulatory filing on Tuesday, Shinpoong said that the new joint ven...
Chung named to head Abbott KoreaAbbott Korea appointed Chung Yoo-suk to head its business in Korea.
Before joining Abbott Korea, Yeom worked for Johnson & Johnson Medical Korea, and has served as CEO of Ab...
|
Humedix’s Elravie filler wins CE certification
Huons Co. announced Tuesday that its affiliate Humedix acquired a CE mark for hyaluronic acid filler Elravie from SGS group.
With the CE mark, Humedix is expected to aggressively explore potential markets of Elravi...
Multinational firms push voluntary retirement in wake of price cuts
About one year after the government forced them to cut their prices, foreign drug makers are scaling back their work forces due to falling profits.
Pfizer Korea recently announced an early retirement program for al...
Major drug firms expected to fare well in 2013
Sales of market leaders like Dong-A Pharmaceutical, Green Cross Corp., Yuhan Corp. and Hanmi Pharmaceutical are expected to increase an average of 7.9 percent this year, according to forecasts by securities firms.
...
Pfizer Korea appoints new executives
LG Group said yesterday it has newly appointed seven executives of three different business units, effective January 1.
Three executives, such as Kim Ga-hyun and Choi Chi-hwan of Established Products Business Unit...
Boryung Pharm signs $15 million Kanarb export dealLocal drug maker Boryung Pharmaceutical said Monday it has signed a contract with R-Pharm of Russia to export newly developed Kanarb (fimasartan) for treatment of hypertension.
...
|
Multinational firms to sell OTC products at pharmacies
Some of multinational drug manufacturers here are preparing to enter the over-the-counter (OTC) business in a more aggressive way as their profits continue to fall in the domestic market after comprehensive price cuts...
